FluroTech Identifies Six Sites For Its High Volume COVID-19 Antigen Test Trial

FluroTech Ltd. (TSXV: TEST) and its subsidiary FluroTest Diagnostics Systems announced today that the clinical trials for its high volume COVID-19 rapid antigen testing system are pushing to its next phase. This trial is being conducted with contract research organization Toolbox Medical Innovations.

FluroTest reported that approximately 600 volunteer participants are currently being identified from six clinical sites across California, Texas, Colorado, Rhode Island, and Florida for the next phase of the trial. The participants are a mix of symptomatic and asymptomatic individuals and the identified sites will compare the diagnostic results from the company’s high volume antigen testing system and a comparator RT-PCR assay.

As reported previously, the clinical trial results will be used to apply for an emergency use authorization from the U.S. FDA and an interim order authorization from the Health Canada.

FluroTech Ltd. last traded at $0.31 on the TSX Venture.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

#PfizerExposed: Did Pfizer Just Admit To “Engineering” Virus For COVID-19 Pill In Response To Project Veritas Video?

After a video of a top Pfizer (NYSE: PFE) executive relaying that the biotech firm...

Saturday, January 28, 2023, 10:59:30 AM

YouTube Updates Misinformation Policies, Will Remove Content on Covid-19 Myths, Alternative Cancer Treatments

Earlier this week, YouTube unveiled a refined policy aimed at curbing medical misinformation on its...

Saturday, August 19, 2023, 07:18:00 AM

Kontrol Energy Begins Initial Production Of BioCloud Units

Kontrol Energy Corp (CSE: KNR) has begun the initial production runs of its BioCloud units....

Thursday, December 3, 2020, 07:17:07 AM

14 Million Americans Slated to Lose Unemployment Benefits, 30 Million Face Eviction Risk By January 1

The Christmas holidays are likely going to be grim for millions of Americans, and not...

Wednesday, November 25, 2020, 12:03:00 PM

Predictiv AI Announces Sale Of 34 ThermalPass Devices

Predictiv AI (TSXV: PAI) continues to see orders flow in for its ThermalPass fever detection...

Wednesday, December 23, 2020, 11:46:46 AM